APP Stock Cash Flow Statements

Applovin Quarterly Cash Flow Statements Chart

Quarterly

Annual

Stock-Based Compensation

Operating Cash Flow

Investing Cash Flow

Financing Cash Flow

Free Cash Flow

Capital Expenditure

Applovin Quarterly Cash Flow Statements Table

Quarterly

Annual

Unit: USD	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31

operating activities
net income	819,531,000	576,419,000	599,204,000	434,420,000	309,969,000	236,183,000	172,233,000	108,639,000	80,357,000	-4,518,000	-79,512,000	23,662,000	-21,799,000	-115,298,000	31,407,000	142,000	14,364,000	-10,575,000
adjustments to reconcile net income to net cash from operating activities:
amortization, depreciation and write-offs	47,053,000	79,887,000	127,837,000	99,635,000	108,541,000	112,667,000	119,111,000	121,797,000	119,892,000	128,208,000	101,577,000	163,830,000	152,688,000	128,989,000	115,654,000	119,436,000	107,156,000	88,817,000
goodwill impairment	0	188,943,000
stock-based compensation	35,745,000	61,281,000	93,833,000	81,557,000	98,724,000	95,253,000	88,049,000	110,839,000	81,253,000	82,966,000	47,669,000	42,147,000	57,156,000	44,640,000	41,349,000	34,725,000	27,144,000	29,959,000
gain on divestiture, net of transaction costs
other	33,531,000	8,086,000	-14,672,000	6,929,000	1,760,000	8,540,000	10,106,000	-2,889,000	-3,446,000	2,429,000	-347,000
changes in operating assets and liabilities:
accounts receivable	-124,169,000	-167,382,000	-229,498,000	-112,345,000	-40,349,000	-84,836,000	-114,483,000	-180,067,000	-32,343,000	65,614,000	-35,479,000	24,066,000	6,834,000	-170,250,000	-101,949,000	-30,118,000	-25,964,000	-43,917,000
prepaid expenses and other assets	72,552,000	-51,861,000		7,038,000	-652,000	26,813,000
accounts payable	6,495,000	32,545,000	134,010,000	40,122,000	-2,603,000	18,056,000	90,619,000	20,220,000	-21,987,000	9,722,000	11,360,000	-21,654,000	-97,831,000	111,604,000	49,267,000	15,409,000	24,566,000	9,370,000
accrued and other liabilities	-12,283,000	103,794,000	181,388,000	-6,654,000	-20,863,000	-19,897,000	60,338,000	33,449,000	-17,027,000	15,994,000	-3,767,000	-10,440,000	-13,343,000	21,138,000	-8,148,000	4,459,000	8,091,000	-1,339,000
net cash from operating activities	772,226,000	831,712,000	701,003,000	550,702,000	454,527,000	392,779,000	343,988,000	199,066,000	229,794,000	288,662,000	163,199,000	174,482,000	106,811,000	-31,719,000	85,015,000	124,560,000	90,457,000	61,819,000
capex	0	0	0	0	0	0	-244,000	-2,273,000	-6,055,000	-2,197,000	-1,444,000	-2,159,000	-1,065,000	-1,943,000	-1,636,000	-1,651,000	-532,000	-121,000
free cash flows	772,226,000	831,712,000	701,003,000	550,702,000	454,527,000	392,779,000	343,744,000	196,793,000	223,739,000	286,465,000	161,755,000	172,323,000	105,746,000	-33,662,000	83,379,000	122,909,000	89,925,000	61,698,000
investing activities
proceeds from divestiture, net of cash divested
purchase of non-marketable equity securities	0	-18,678,000	0	-650,000	-48,000,000	-28,333,000		-100,000	0	-16,834,000
other investing activities	-23,154,000	-3,986,000		-2,546,000	-5,267,000	-3,302,000
net cash from investing activities	401,548,000	-22,664,000	-367,000	-6,396,000	-68,356,000	-31,635,000	-6,804,000	-15,833,000	-42,217,000	-12,975,000	22,286,000	-42,010,000	-292,001,000	-1,059,743,000	-8,678,000	-183,070,000	-1,004,909,000	-18,273,000
financing activities
repurchases of common stock	-271,518,000	-1,000,911,000
payment of withholding taxes related to net share settlement	-70,983,000	-185,667,000				-80,144,000		-59,243,000
principal repayments of debt			-3,538,469,000	-8,891,000	-8,891,000	-668,972,000	-7,500,000	-473,838,000	-8,329,000	-8,327,000
payments of licensed asset obligation	0	-13,532,000					-11,856,000	0	0	-15,254,000	0	0	0	-17,374,000
proceeds from issuance of debt	0	200,000,000	3,542,511,000	0	0	1,072,330,000
proceeds from issuance of common stock upon exercise of stock options and purchase of espp shares			12,998,000	9,702,000
other financing activities	-4,371,000	-7,436,000		-5,476,000	-5,089,000	-5,384,000
net cash from financing activities	-537,377,000	-1,002,217,000	-523,157,000	-441,075,000	-361,000,000	-424,612,000	-170,524,000	-724,154,000	-556,698,000	-111,415,000	-55,411,000	-136,391,000	-269,622,000	-65,424,000	1,446,939,000	-75,159,000	1,337,392,000	400,374,000
effect of foreign exchange rate on cash and cash equivalents	5,187,000	2,782,000		3,916,000	-1,058,000	-2,348,000		-2,815,000	-545,000	1,137,000		-4,133,000	-6,884,000	-362,000		-457,000	-272,000	-80,000
net increase in cash and cash equivalents, including cash classified within current assets of discontinued operations
less: net (decrease) in cash classified within current assets of discontinued operations
net increase in cash and cash equivalents						-65,816,000				165,409,000		-8,052,000	-461,696,000	-1,157,248,000		-134,126,000	422,668,000	443,840,000
cash and cash equivalents at beginning of the period	-44,381,000	741,411,000		0	0	502,152,000								2,570,504,000		0	0	317,235,000
cash and cash equivalents at end of the period	641,584,000	551,024,000	173,815,000	107,147,000	24,113,000	436,336,000		-543,736,000	-369,666,000	1,245,893,000		-8,052,000	-461,696,000	1,413,256,000		-134,126,000	422,668,000	761,075,000
adjustments to reconcile net income to operating activities:
proceeds from exercise of stock options		5,329,000				9,782,000	3,125,000	11,272,000	3,629,000	2,906,000	3,754,000	5,860,000	7,763,000	8,110,000	5,670,000	7,598,000	5,006,000	12,882,000
net decrease in cash and cash equivalents		-190,387,000
impairment of investments
loss on settlement of debt															1,384,000	0	0	16,852,000
change in operating right-of-use assets
amortization of debt issuance costs and discount							-300,000	3,080,000	3,333,000	3,250,000	2,993,000	2,865,000	3,574,000	3,246,000	3,845,000	2,600,000	2,077,000	4,303,000
loss on disposal of long-lived assets
prepaid expenses and other current assets							-40,975,000	30,806,000	14,302,000	-16,413,000	66,517,000	-41,249,000	25,468,000	-54,461,000	10,137,000	-14,610,000	-74,076,000	-18,775,000
other assets							-63,509,000	-55,162,000	-1,881,000	-1,136,000	-72,727,000	-7,649,000	1,935,000	1,098,000	-53,667,000	2,460,000	4,797,000	472,000
operating lease liabilities							-6,359,000	-5,149,000	-3,617,000	-3,487,000	-3,553,000	-3,299,000	-6,000,000	-6,046,000	-8,584,000	-6,187,000	-6,452,000	-5,631,000
deferred revenue							-568,000	4,327,000	7,525,000	2,573,000	-2,806,000	-2,619,000	-6,656,000	-2,630,000	-6,604,000	-4,976,000	-1,333,000	-994,000
acquisitions of businesses and intangible assets
purchase of property and equipment							-244,000	-183,000	-3,749,000	-70,000	-41,000	-221,000	-115,000	-285,000	-428,000	-309,000	-532,000	-121,000
proceeds from sale of assets and other
payments of withholding taxes related to net share settlement
payments of deferred acquisition costs							-22,400,000	-10,274,000	0	-1,229,000	-19,186,000	-33,286,000	-70,002,000	-1,710,000	-2,404,000	-74,099,000	-5,320,000	-152,245,000
payments of debt issuance cost
principal payments of finance leases
effect of foreign exchange rate on cash, cash equivalents, and restricted cash equivalents
net increase in cash, cash equivalents, and restricted cash equivalents
cash, cash equivalents, and restricted cash equivalents at beginning of the period
acquisition of intangible assets				-3,200,000
repurchases of stock				-228,448,000	0	-752,224,000		-581,492,000	-507,204,000	-64,897,000
payment of withholding taxes related to net share settlement of equity awards				-207,962,000
change in operating right-of-use asset							6,110,000	4,839,000	3,433,000	3,460,000	3,382,000	3,167,000	4,807,000	5,751,000	8,114,000	5,932,000	6,471,000	5,796,000
impairment and loss in connection with sale of long-lived assets
purchase of investments and other
proceeds from debt issuance
proceeds from the issuance of common stock through espp
proceeds from issuance of common stock in initial public offering, net of issuance costs as adjusted for cost reimbursement															0	988,000
payments of related party notes
effect of foreign exchange rate on cash, cash equivalents and restricted cash equivalents
net increase in cash, cash equivalents and restricted cash equivalents
cash, cash equivalents and restricted cash equivalents at beginning of the period							0	0	0	1,080,484,000	0	0
cash, cash equivalents and restricted cash equivalents at end of the period
changes in operating assets and liabilities, net of effect of acquisitions:
acquisitions, net of cash acquired								-13,460,000	-36,162,000	-2,194,000	-4,129,000	-41,346,000	-248,536,000	-1,045,816,000	-7,693,000	-181,777,000	-1,012,860,000	-4,152,000
capitalized software development costs								-2,090,000	-2,306,000	-2,127,000	-1,403,000	-1,938,000	-950,000	-1,658,000	-1,208,000	-1,342,000
proceeds from sale of assets								0	0	8,250,000
principal payments on finance leases								-5,276,000	-5,468,000	-5,447,000
payment of debt issuance cost								-584,000
proceeds from revolving credit facility
proceeds from the issuance of common stock under the employee stock purchase plan								0				0
net (decrease) in cash and cash equivalents
payment of withholding taxes related to net share settlement of restricted stock units										-19,167,000
lease modification and abandonment of leasehold improvements
loss on extinguishments of acquisition related contingent consideration
purchase of non-marketable investments and other											-9,796,000	0	-42,400,000	-14,146,000	0	-1,000,000	0	-14,000,000
proceeds from other investing activities											655,000	1,495,000	0	2,162,000	651,000	1,358,000
proceeds from sale of long-lived assets
proceeds from debt issuance, net of issuance costs															1,484,330,000	0	0	844,729,000
payments of debt principal											-8,328,000	-8,327,000	-4,578,000	-4,577,000	-8,328,000	-4,577,000	-404,578,000	-302,327,000
proceeds from issuance of common stock
proceeds from the issuance of class a common stock under employee stock purchase plan
payments of deferred ipo costs																		-1,825,000
proceeds from issuance of common stock in initial public offering, including cost reimbursement
payments of finance leases												-5,773,000	-6,150,000	-6,176,000	-5,581,000	-5,069,000	-3,781,000	-840,000
net unrealized gain on fair value remeasurements
net (gain) loss on foreign currency remeasurements
repurchases of stock - repurchase program													-200,318,000	-43,697,000
net unrealized gains on fair value remeasurements														957,000
net gain on foreign currency remeasurement														-457,000			2,257,000	-1,305,000
change in fair value of contingent consideration															0
net unrealized gains on fair value remeasurement of financial instruments															464,000	550,000	1,359,000	-11,214,000
net (gain) loss on foreign currency remeasurement

We provide you with 20 years of cash flow statements for Applovin stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as operating cash flows, cash levels, capital expenditures, profits, stock-based compensations and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Applovin stock. Explore the full financial landscape of Applovin stock with our expertly curated income statements.

The information provided in this report about Applovin stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.